share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gibson Christopher

SEC ·  Aug 10 04:58
Summary by Futu AI
Recursion Pharmaceuticals, Inc. CEO Christopher Gibson completed a sale of company stock over two days, on August 7 and August 8, 2024. Gibson sold a total of 50,000 shares of Class A Common Stock in open market transactions. On the first day, 30,000 shares were sold at a price of $7.10 per share, followed by 20,000 shares at $6.50 per share the next day. The total market value of the disposed shares amounted to $343,000. Following these transactions, Gibson directly holds 758,738 shares of Recursion Pharmaceuticals.
Recursion Pharmaceuticals, Inc. CEO Christopher Gibson completed a sale of company stock over two days, on August 7 and August 8, 2024. Gibson sold a total of 50,000 shares of Class A Common Stock in open market transactions. On the first day, 30,000 shares were sold at a price of $7.10 per share, followed by 20,000 shares at $6.50 per share the next day. The total market value of the disposed shares amounted to $343,000. Following these transactions, Gibson directly holds 758,738 shares of Recursion Pharmaceuticals.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated